Acorai
Signal active
Organization
Contact Information
Overview
Acorai is building a non-invasive heart failure monitoring platform with direct intracardiac pressure monitoring (ICPM) at its core. Acorai offers accurate and cost-efficient heart failure care using patented technology that leverages a novel combination of sensor technologies and machine learning to enable non-invasive ICPM, the only proven way to improve outcomes in HF patients. The device has been clinically validated, designated FDA Breakthrough Device and will be entering the market in 2025.
Acorai is a MedTech company with HQ in Sweden. The company has 20 FTE across 12 countries, with offices in Sweden and the UK.
About
Industries
Health Care, Pharmaceutical, Medical Device
Founded
2019
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Acorai headquartered in Europe, operates in the Health Care, Pharmaceutical, Medical Device sector. The company focuses on Health Care and has secured $1.1B in funding across 96 round(s). With a team of 11-50 employees, Acorai is actively contributing to advancements in Health Care. Their latest funding round, Non Equity Assistance - Acorai, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
8
Investors
1
Lead Investors
0
Total Funding Amount
$11.4M
Details
4
Acorai has raised a total of $11.4M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 1.2M | ||
| 2022 | Seed | 1.5M | ||
| 2023 | Seed | 1.0M | ||
| 2024 | Seed | 4.5M |
Investors
Acorai is funded by 23 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Solardis Health Ventures | - | FUNDING ROUND - Solardis Health Ventures | 4.5M |
| Acorai | - | FUNDING ROUND - Acorai | 4.5M |
| Chris Gasteratos | - | FUNDING ROUND - Chris Gasteratos | 4.5M |
| Acorai | - | FUNDING ROUND - Acorai | undefined |
Recent Activity
There is no recent news or activity for this profile.